Clinical and molecular determinants of PSA response to bipolar androgen therapy in prostate cancer.
Caputo SA, Hawkins M, Jaeger EB, Fleming W, Casado C, Manogue C, Huang M, Lieberman A, Light M, Sussman IP, Miller P, Barata PC, Lewis BE, Layton JL, Ledet EM, Antonarakis ES, Sartor O.
Caputo SA, et al. Among authors: lewis be.
Prostate. 2023 Jun;83(9):879-885. doi: 10.1002/pros.24529. Epub 2023 Apr 4.
Prostate. 2023.
PMID: 36959766